CA Patent

CA2634993A1 — Concentrated liquid thyroid hormone composition

Assigned to Intervet International BV · Expires 2007-07-12 · 19y expired

What this patent protects

This invention is directed generally to a liquid pharmaceutical composition comprising at least one thyroid hormone (particularly a composition further comprising at least one cyclodextrin compound), a process for making such a composition, and a method of using such a compositio…

USPTO Abstract

This invention is directed generally to a liquid pharmaceutical composition comprising at least one thyroid hormone (particularly a composition further comprising at least one cyclodextrin compound), a process for making such a composition, and a method of using such a composition to treat a condition associated with impaired thyroid hormone function.

Drugs covered by this patent

Patent Metadata

Patent number
CA2634993A1
Jurisdiction
CA
Classification
—
Expires
2007-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Intervet International BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.